Pharmaceutical Drug Delivery Market

The report "Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031" The global pharmaceutical drug delivery market size is expected to reach USD 2,922.82 billion by 2031 from USD 2,152.45 billion in 2026, recording a CAGR of 6.3% during the forecast period.

Browse 1700 market data Tables and 300 Figures spread through 1500 Pages and in-depth TOC on "Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html

The global market is growing due to the rising prevalence of chronic diseases globally and increased usage of biologics, as well as complex therapies. This trend is driving the need for delivery solutions that facilitate convenience, precision, and provide the patient with the opportunity for self-administration within diverse healthcare systems. Several advanced technologies, such as autoinjectors, inhalers, wearable injectors, lipid nanoparticles, and controlled release formulations, are being rapidly adopted, which reflects the global trend toward advanced treatment modalities that include mRNA therapies, cell and gene therapies, and high viscosity biologics. These methods maintain the drug stability and pave the way for the correct drug dosage and greater patient compliance.

However, the market is encountering issues related to the elevated cost and technical intricacy of developing drug-device combination products. High-tech manufacturing, strict quality standards, and the use of special materials lead to longer development times. Furthermore, worldwide regulatory agencies, such as the FDA, EMA, PMDA, NMPA, and CDSCO, are continuously raising the bar in terms of safety, usability, and device performance requirements, which thus constitutes an additional challenge for manufacturers.

By route of administration, the injectable drug delivery segment is projected to hold a major market share in 2031

Injectable drug delivery is emerging as a major segment due to the rapid shift toward biologics, biosimilars, and advanced therapies that require parenteral administration for efficacy and stability. The increasing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, is significantly driving the demand for injectable treatments, as these conditions often require precise, high-potency, and fast-acting drug delivery systems. Injectables offer key advantages, including rapid onset of action, higher bioavailability, and accurate dosing, making them essential for complex therapies, such as monoclonal antibodies, vaccines, and gene and cell therapies. Additionally, the growing adoption of long-acting injectables, depot formulations, and targeted delivery systems is improving therapeutic outcomes and reducing dosing frequency, further accelerating their use across multiple applications. Technological advancements such as prefilled syringes, autoinjectors, and wearable injectors are also transforming the market by enhancing patient convenience, safety, and adherence, while enabling a shift toward self-administration and home-based care. Coupled with expanding immunization programs and increasing healthcare access in emerging markets, these factors collectively position injectable drug delivery as the fastest-growing segment in the global pharmaceutical drug delivery market.

By facility of use, the formulations segment is anticipated to register the highest CAGR from 2026 to 2031

The formulations segment is expected to witness the fastest growth rate during the forecast period due to the rising demand for drug administration across diverse care settings. The increasing prevalence of chronic and acute diseases, coupled with growing patient volumes, is driving higher consumption of drug formulations across these end users. Additionally, the shift toward decentralized healthcare, particularly the expansion of outpatient services and home-based care, is accelerating the adoption of drug delivery solutions beyond traditional hospital settings. Advancements in drug delivery devices enabling safe and convenient administration are further supporting this transition. While hospitals continue to account for the largest share due to their role in complex treatments, the rapid growth of home care and ambulatory settings is collectively driving the high CAGR of the formulation end users segment in the pharmaceutical drug delivery market.

Asia Pacific is likely to record the highest growth rate between 2026 and 2031

The Asia Pacific region is expected to register the highest CAGR in the pharmaceutical drug delivery market during the forecast period. This regional market is primarily driven by the rapidly expanding patient population, increasing prevalence of chronic diseases, and rising demand for advanced therapeutics across China, India, and Japan. The region is witnessing significant improvements in healthcare infrastructure, along with increased healthcare spending and expanding access to medical services. Government initiatives to strengthen healthcare systems, promote local pharmaceutical manufacturing, and improve access to essential medicines are further supporting market growth. Additionally, the growing presence of global pharmaceutical companies and increased investments in research and development are accelerating the adoption of advanced drug delivery technologies. The increasing demand for biologics, biosimilars, and vaccines, coupled with a strong shift toward self-administration and home-based care, is also contributing to the rapid uptake of innovative drug delivery systems in the region. Furthermore, cost advantages in manufacturing and the expansion of contract development and manufacturing organizations (CDMOs) make the region a key hub for pharmaceutical production.

Key Market Players

Some of the prominent players operating in the global pharmaceutical drug delivery formulations market include Johnson & Johnson Services (US), Pfizer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Novartis AG (Switzerland), GSK plc (UK), AbbVie Inc. (US), Sanofi (France), Merck & Co., Inc. (US), and Amgen Inc. (US). Some of the prominent players operating in the global pharmaceutical drug delivery devices market include BD (US), Cardinal Health (US), SHL Medical (Switzerland), Gerresheimer AG (Germany), and Stevanato Group (Italy).

Don’t miss out on business opportunities in Pharmaceutical Drug Delivery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]